Los Angeles Capital Management’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$5.04K Buy
2022
Q4
Sell
2022
Q3
$1.15M Hold
2022
Q2
$1.11M Sell
2022
Q1
$1.73M Buy
2021
Q2
Sell
2021
Q1
$218K Sell
2020
Q4
$278K Buy